Immunosuppression and immune monitoring after renal transplantation
- PMID: 16398715
- DOI: 10.1111/j.1525-139X.2005.00098.x
Immunosuppression and immune monitoring after renal transplantation
Abstract
Monitoring of immunosuppression therapy in renal transplant recipients is essential for good patient and graft survival. Monitoring includes frequent laboratory assays of serum immunosuppression levels, patient visits to assess and treat side effects, and vigilance for medication interactions. We review the various immunosuppression medications commonly used in renal transplantation, including usual dosing and side effects. Monitoring assays are discussed, as well as the frequency of monitoring and patient visits. Finally, we discuss several common clinical scenarios that often require adjustment of immunosuppression medications or regimens.
Similar articles
-
Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.Transpl Immunol. 2008 Nov;20(1-2):3-5. doi: 10.1016/j.trim.2008.08.008. Epub 2008 Sep 4. Transpl Immunol. 2008. PMID: 18773959
-
Immunopharmacologic therapy in renal transplantation.Pharmacotherapy. 1996 Jul-Aug;16(4):562-75. Pharmacotherapy. 1996. PMID: 8840362 Review.
-
Immunologic control for polyomavirus infection after kidney transplantation.Nephron Clin Pract. 2008;108(2):c148-54. doi: 10.1159/000115327. Epub 2008 Feb 6. Nephron Clin Pract. 2008. PMID: 18259101
-
Management of the well renal transplant recipient: outpatient surveillance and treatment recommendations.Semin Dial. 2005 Nov-Dec;18(6):520-8. doi: 10.1111/j.1525-139X.2005.00099.x. Semin Dial. 2005. PMID: 16398716 Review.
-
A delicate balance: negotiating renal transplantation, immunosuppression and adherence to medical regimen.Health (London). 2007 Oct;11(4):497-512. doi: 10.1177/1363459307080875. Health (London). 2007. PMID: 17855470
Cited by
-
Pharmacologic targeting of regulatory T cells for solid organ transplantation: current and future prospects.Drugs. 2015 Nov;75(16):1843-52. doi: 10.1007/s40265-015-0487-6. Drugs. 2015. PMID: 26493288 Review.
-
Lessons Learned: Early Termination of a Randomized Trial of Calcineurin Inhibitor and Corticosteroid Avoidance Using Belatacept.Am J Transplant. 2017 Oct;17(10):2712-2719. doi: 10.1111/ajt.14377. Epub 2017 Jul 3. Am J Transplant. 2017. PMID: 28556519 Free PMC article. Clinical Trial.
-
Probability, predictors, and prognosis of posttransplantation glomerulonephritis.J Am Soc Nephrol. 2009 Apr;20(4):843-51. doi: 10.1681/ASN.2008050454. Epub 2009 Feb 4. J Am Soc Nephrol. 2009. PMID: 19193778 Free PMC article.
-
Trends in the Medical Complexity and Outcomes of Medicare-insured Patients Undergoing Kidney Transplant in the Years 1998-2014.Transplantation. 2019 Nov;103(11):2413-2422. doi: 10.1097/TP.0000000000002670. Transplantation. 2019. PMID: 30801531 Free PMC article.
-
Immune phenotype predicts risk for posttransplantation squamous cell carcinoma.J Am Soc Nephrol. 2010 Apr;21(4):713-22. doi: 10.1681/ASN.2009060669. Epub 2010 Jan 28. J Am Soc Nephrol. 2010. PMID: 20110382 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical